This company has been marked as potentially delisted and may not be actively trading. Therapeutics Acquisition (RACA) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock RACA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period The New Gold Rush in Rare Disease Treatments and Merck KGaA’s Acquisition of SpringWorks TherapeuticsFebruary 20, 2025 | msn.comBlackstone Life Sciences and Anthos Therapeutics Announce Agreement for Anthos to be Acquired by Novartis for up to $3.1 BillionFebruary 12, 2025 | businesswire.comMaxCyte, TG Therapeutics sign strategic platform license to advance autoimmune cell therapeutics programsFebruary 12, 2025 | msn.comRoche to Complete $1.5 Billion Acquisition of U.S. Biopharma Company PoseidaJanuary 8, 2025 | msn.comNRx stock rallies 35% on equity purchases, clinic acquisitionJanuary 6, 2025 | seekingalpha.comHold Rating Issued Amid Acquisition Uncertainty for Revance TherapeuticsJanuary 6, 2025 | markets.businessinsider.comGalera Therapeutics Acquires Nova Pharmaceuticals to Advance Breast Cancer TreatmentJanuary 2, 2025 | msn.comGalera Therapeutics sidesteps liquidation, acquires New York biotech companyDecember 31, 2024 | bizjournals.comMarinus Therapeutics to be acquired by Swedish company in $151M dealDecember 30, 2024 | bizjournals.comAchilles Therapeutics sells technology assets to AstraZeneca for $12MDecember 24, 2024 | markets.businessinsider.comAchilles Therapeutics Sells Technology Assets to AstraZeneca for $12 MillionDecember 24, 2024 | marketwatch.comRelmada Therapeutics commences exploration of strategic alternativesDecember 9, 2024 | markets.businessinsider.comRoche to Acquire Cell Therapy Maker Poseida Therapeutics in $1.5 Billion DealNovember 26, 2024 | msn.comAutolus Therapeutics Receives ‘Buy’ Rating: Aucatzyl’s FDA Approval and Strategic Launch Plan Bolster Market PositionNovember 12, 2024 | markets.businessinsider.comRevance Therapeutics Faces Strategic Uncertainty Amid Financial Shortfalls and Acquisition ChallengesNovember 9, 2024 | markets.businessinsider.comAppili Therapeutics’ FDA Alignment and Aditxt AcquisitionNovember 2, 2024 | markets.businessinsider.comNeumora Therapeutics: A Story Of A Class II BiotechOctober 16, 2024 | seekingalpha.comRevance Therapeutics falls as Crown Labs didn't start tender offer by deadline (update)September 16, 2024 | msn.comRevance Therapeutics to Be Acquired at $924 Million Enterprise ValueAugust 12, 2024 | marketwatch.comStrong Buy on Tenaya Therapeutics: Regulatory Milestones and Financial Strategy Driving GrowthAugust 9, 2024 | markets.businessinsider.comAbbVie finalizes acquisition of Cerevel TherapeuticsAugust 3, 2024 | investing.comJapan's Otsuka Pharma to pay up to $1.1 bln to acquire Jnana TherapeuticsAugust 1, 2024 | reuters.comClick Therapeutics acquires assets from Better TherapeuticsMay 23, 2024 | msn.comPhiladelphia-based Century Therapeutics Acquires Boston Biotechnology Firm, Clade TherapeuticsApril 26, 2024 | msn.comHalozyme TherapeuticsApril 6, 2024 | forbes.comRACA/USD - RACA US DollarFebruary 27, 2024 | investing.comKaruna Therapeutics Inc KRTXJanuary 23, 2024 | morningstar.comMTG Therapeutics Acquires Worldwide License Agreement For Precision's Cell Therapy ProgramJanuary 9, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Sarepta Therapeutics (SRPT), AlloVir (ALVR) and Bristol-Myers Squibb (BMY)December 26, 2023 | markets.businessinsider.comMerger Alert: Tryp Therapeutics Signs With Australian Drug Delivery Innovator, Details HereDecember 11, 2023 | msn.comRoche to acquire Carmot Therapeutics for $2.7 billionDecember 4, 2023 | news.yahoo.comAstria Therapeutics: Promising Clinical Data and New Licensing Agreement Bolster Buy RatingNovember 14, 2023 | markets.businessinsider.comAvenue Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate HighlightsNovember 13, 2023 | markets.businessinsider.comHLTH 2023: Sidekick Health expands into prescription digital therapeutics with acquisition of aidhereOctober 11, 2023 | msn.comAmgen acquires Horizon Therapeutics for $27.8bnOctober 9, 2023 | msn.comAmgen Concludes Horizon Therapeutics AcquisitionOctober 8, 2023 | markets.businessinsider.comAmgen completes acquisition of Horizon TherapeuticsOctober 6, 2023 | reuters.comBoard Member at Nektar Therapeutics Acquires Company Stock Options Worth 85,000 SharesSeptember 21, 2023 | benzinga.comFTC settles with Amgen over $27.8 billion takeover of Horizon TherapeuticsSeptember 1, 2023 | msn.comBiopharma Giant Amgen Reaches Agreement With FTC On Acquisition of Horizon TherapeuticsSeptember 1, 2023 | msn.comNovartis Completes Acquisition of Chinook TherapeuticsAugust 14, 2023 | finance.yahoo.comFresh Tracks Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 11, 2023 | technews.tmcnet.comHDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition CorpAugust 11, 2023 | benzinga.comHDL Therapeutics to Go Public in SPAC DealAugust 11, 2023 | marketwatch.comSPAC MedTech Acquisition shareholders approve TriSalus mergerAugust 9, 2023 | msn.comRegeneron buying small cap Decibel Therapeutics for $4 a shareAugust 9, 2023 | msn.comTG Therapeutics to Host Conference Call on Second Quarter 2023 Financial Results and Business UpdateJuly 31, 2023 | technews.tmcnet.comDigital Therapeutics Market to Grow Rapidly at a CAGR of 29.4% by 2030 | DataM IntelligenceJuly 28, 2023 | benzinga.comBetter Therapeutics, Inc. (BTTX) Gets a Hold from LifeSci CapitalJuly 11, 2023 | markets.businessinsider.comLucy Scientific Discovery Makes Buyout Offer for Pasithea TherapeuticsJune 7, 2023 | marketwatch.com Get Therapeutics Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for RACA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RACA Media Mentions By Week RACA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RACA News Sentiment▼0.000.94▲Average Medical News Sentiment RACA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RACA Articles This Week▼00▲RACA Articles Average Week Get the Latest News and Ratings for RACA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Therapeutics Acquisition and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies MBX Biosciences News Aerovate Therapeutics News BioAge Labs News Cybin News Virios Therapeutics News OS Therapies News Eliem Therapeutics News Actinium Pharmaceuticals News Aadi Bioscience News Eagle Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RACA) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Therapeutics Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Therapeutics Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
